The activity of immunoregulatory T cells mediating active tolerance is potentiated in nonobese diabetic mice by an IL-4-based retroviral gene therapy

Journal of Immunology

Volumn 166, Issue 8, 2001, Pages 4973-4980

  Yamamoto, A M ^a   Chernajovsky, Y ^a   Lepault, F ^a   Podhajcer, O ^a   Feldmann, M ^a   Bach, J F ^a   Chatenoud, L ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DIABETOGENESIS; DISEASE TRANSMISSION; FEMALE; GENE OVEREXPRESSION; GENE THERAPY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RETROVIRUS; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

EID: 0035871805     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.8.4973     Document Type: Article

References (38)

1. Thymus and reproduction: Sex-linked dysgenesia of the gonad after neonatal thymectomy in mice
2. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
3. The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients
4. Control of immune pathology by regulatory T cells
5. The significance of immune suppression in normal self tolerance
6. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity
7. Tissue-specific suppressor T cells involved in self-tolerance are activated extrathymically by self-antigens
8. Self tolerance and localized autoimmunity: Mouse models of autoimmune disease that suggest tissue-specific suppressor T cells are involved in self tolerance
9. Lack of L-selectin expression by cells transferring diabetes in NOD mice: Insights into the mechanisms involved in diabetes prevention by Mel-14 antibody treatment
10. + T cells that prevent diabetes onset in nonobese diabetic mice
11. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice
12. + thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse
13. Insulin-dependent diabetes mellitus as an autoimmune disease
14. + immunoregulatory T cells that control autoimmune diabetes
15. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
16. Pancreatic islet-specific T-cell clones from nonobese diabetic mice
17. + Th1 and Th2 cells derived from the spleens of diabetic NOD mice
18. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
19. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice
20. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice
21. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes
22. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and down-regulates autoimmunity to various β-cell antigens
23. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent
24. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
25. Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor
26. Lymphocytes from diabetics suppress insulin release in vitro
27. Expression of homing and adhesion molecules in infiltrated islets of Langerhans and salivary glands of nonobese diabetic mice
28. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice
29. T helper cell subsets in insulin-dependent diabetes
30. Mechanism underlying counterregulation of autoimmune diabetes by IL-4
31. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis
32. Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice
33. Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding au interferon-γ/IgG1 fusion protein
34. TGF-β1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice
35. Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice
36. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes: A gene therapy model for autoimmune diabetes
37. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis